Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>


Close X


Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more

Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Mark Manner


(615) 742-6298 TEL
(615) 742-2897 FAX

Mark Manner


(615) 742-6298 TEL
(615) 742-2897 FAX
(615) 742-6298 TEL
(615) 742-2897 FAX

For more than 35 years, Mark Manner has provided counsel to corporate boards, executives and significant shareholders on governance, securities issuances and disclosures, private equity and mergers and acquisitions. He applies his years of experience to effectively navigate complex interpersonal relationships in order to resolve issues and enhance shareholder value. He has substantial experience structuring and negotiating complex mergers, acquisitions, private equity and securities transactions, initial and follow-on securities offerings, venture capital financings and leveraged buyouts.

Mark has earned a national reputation in corporate law and has been recognized by clients and peers in Chambers USA as a "''fabulous lawyer' ... He is singled out by interviewees for his significant expertise in advising clients on a diverse range of matters, including securities offerings, corporate governance, private equity transactions and M&A." Chambers USA also recognized Mark for his "well-established reputation advising clients on mergers and acquisitions, securities offerings and corporate governance matters in the healthcare industry. He is also noted for his handling of venture capital financing." (from Chambers USA 2018) Working closely with senior management, boards of directors and shareholders, Mark's practice includes:

  • Leadership on corporate governance issues.
  • Guidance on SEC disclosure requirements and filings.
  • Advice related to capital markets issues.
  • Counsel on SEC regulations and compliance.
  • Representation in mergers, acquisitions and other strategic corporate transactions.

Prior to joining Bass, Berry & Sims, Mark was a founding member and served as the managing shareholder at Harwell Howard Hyne Gabbert & Manner, P.C. Previously he worked in Washington, D.C. with the Appellate Section of the Antitrust Division of the U.S. Department of Justice, and served as a Special Assistant U.S. Attorney in Alexandria, Virginia.


Nashville Bar Association

Tennessee Bar Association

American Health Lawyers Association (AHLA)

Life Science Tennessee — Founding Member, Board of Directors (former), Of Counsel

Nashville Health Care Council — Board of Directors (former)

Tennessee Technology Development Corporation — Board of Directors (former)

The Land Trust for Tennessee — Chair, Board of Directors

Dyer Observatory of Vanderbilt University — Adviser

Long Mountain Observatory of Montgomery Bell Academy — Adviser

KELT-North – Survey for Transiting Exoplanets — Team Member


View More

Representative Experience

View More

Additional Experience

Counselor and Senior Adviser to Control Shareholders, Boards of Directors and Executive Management

Mark has advised significant shareholders, senior executive management and boards of directors of public and private companies on corporate governance, securities and debt issuances, strategic acquisitions, proxy and control contests and high level business strategy and implementation. Companies represented include:

  • Diversicare Healthcare Services, Inc.
  • ALS Education, Inc.
  • American Health Companies, Inc.
  • Aegis Health Group, Inc.
  • Tractor Supply Company
  • The Car Park
  • Central Parking Corporation
  • Utah Medical Products, Inc.
  • National Healthcare Corporation (NHC)
  • National Health Investors, Inc. (NHI)
  • Counsel Corporation
  • Pharmerica, Inc.
  • American HomePatient, Inc.
  • Stadtlander Drug Company
  • BioMimetic Pharmaceuticals, Inc.
  • Clintrials Research, Inc.
  • International Clinical Laboratories, Inc.
  • Advocat, Inc.
  • Wessex Corporation
  • Celeris Corp.

Media Mentions

View More


Chambers USA — Corporate/M&A, Healthcare (2005-2018)

Best Lawyers in America® — Nashville Securities/Capital Markets Law "Lawyer of the Year" (2019); Nashville Corporate Governance Law "Lawyer of the Year" (2011, 2012, 2014)

Best Lawyers in America® — Corporate Governance Law; Corporate Law; Healthcare Law; Mergers and Acquisitions Law; Securities/Capital Markets Law (1995-2019)

Martindale-Hubbell — AV Preeminent® Peer Review Rated

Nashville Post "In Charge" — Legal Sector (2015-2018)

Mid-South Super Lawyers (2006-2010, 2016-2017)

Top 100 Tennessee Super Lawyers (2007, 2009)

Nashville Business Journal "Best of the Bar" (2003-2005, 2012)

Nashville Post "101 Best Lawyers" (2011)

Nashville Business Journal "Healthcare 100" (2004-2007)

Memphis State University Law Review — Editor-in-chief


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.